Total Payments
$45,356
2024 Payments
$568.89
Companies
31
Transactions
102
Medicare Patients
3,146
Medicare Billing
$686,084
Payment Breakdown by Category
Consulting$31,500 (69.5%)
Other$9,505 (21.0%)
Food & Beverage$3,455 (7.6%)
Travel$895.92 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,500 | 7 | 69.5% |
| Honoraria | $9,505 | 3 | 21.0% |
| Food and Beverage | $3,455 | 89 | 7.6% |
| Travel and Lodging | $895.92 | 3 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure GmbH | $22,500 | 1 | $0 (2023) |
| Novocure Inc. | $21,560 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $173.87 | 5 | $0 (2023) |
| Allergan Inc. | $159.64 | 2 | $0 (2019) |
| Sirtex Medical Inc | $116.67 | 1 | $0 (2019) |
| Medtronic USA, Inc. | $94.40 | 2 | $0 (2020) |
| Amgen Inc. | $92.58 | 6 | $0 (2021) |
| Janssen Biotech, Inc. | $72.42 | 5 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $71.84 | 3 | $0 (2023) |
| SOBI, INC | $57.81 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $568.89 | 10 | Novocure Inc. ($487.96) |
| 2023 | $25,610 | 13 | Novocure GmbH ($22,500) |
| 2022 | $713.59 | 19 | Novocure Inc. ($387.02) |
| 2021 | $137.38 | 5 | Novocure Inc. ($108.31) |
| 2020 | $4,615 | 7 | Novocure Inc. ($4,533) |
| 2019 | $5,098 | 16 | Novocure Inc. ($4,801) |
| 2018 | $5,689 | 16 | Novocure Inc. ($5,543) |
| 2017 | $2,924 | 16 | Novocure Inc. ($2,722) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $150.23 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $29.91 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Hematology/Oncology | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $27.11 | General |
| Category: Oncology | ||||||
| 06/20/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/04/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $158.39 | General |
| Category: Oncology | ||||||
| 02/03/2024 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $98.57 | General |
| 01/13/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/08/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Novocure Inc. | — | Honoraria | Cash or cash equivalent | $2,505.00 | General |
| 11/02/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/26/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $172.85 | General |
| 08/31/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $145.36 | General |
| 08/29/2023 | EMD Serono, Inc. | TEPMETKO (Drug) | Food and Beverage | Cash or cash equivalent | $22.67 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Oncology | ||||||
| 07/06/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Oncology | ||||||
| 03/04/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $131.08 | General |
| Category: Oncology | ||||||
| 02/23/2023 | Siemens Medical Solutions USA, Inc. | TrueBeam (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2023 | Novocure GmbH | Optune (Device) | Consulting Fee | Cash or cash equivalent | $22,500.00 | General |
| Category: Oncology | ||||||
| 01/05/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/02/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Oncology | ||||||
| 11/29/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 756 | 2,594 | $566,686 | $165,052 |
| 2022 | 16 | 778 | 2,760 | $586,765 | $178,004 |
| 2021 | 18 | 762 | 2,390 | $612,078 | $161,709 |
| 2020 | 18 | 850 | 2,756 | $753,298 | $181,320 |
Total Patients
3,146
Total Services
10,500
Medicare Billing
$686,084
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 60 | 243 | $116,883 | $35,543 | 30.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 41 | 864 | $98,496 | $29,458 | 29.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 75 | 620 | $52,252 | $15,720 | 30.1% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 46 | 47 | $57,981 | $15,006 | 25.9% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 47 | 68 | $40,914 | $11,825 | 28.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 70 | 70 | $39,340 | $11,487 | 29.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 80 | 252 | $38,808 | $11,469 | 29.6% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 74 | 79 | $33,654 | $9,972 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 162 | $37,746 | $9,822 | 26.0% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 34 | 38 | $21,774 | $6,541 | 30.0% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 38 | 42 | $8,778 | $2,542 | 29.0% |
| 77470 | Special radiation treatment | Facility | 2023 | 24 | 26 | $7,234 | $2,144 | 29.6% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 32 | 66 | $7,046 | $1,931 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,780 | $1,592 | 27.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 63 | 280 | $134,680 | $41,710 | 31.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 38 | 889 | $101,346 | $31,194 | 30.8% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 70 | 626 | $51,958 | $16,021 | 30.8% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 74 | 300 | $46,200 | $13,995 | 30.3% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 39 | 40 | $42,760 | $13,024 | 30.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 40 | 65 | $37,245 | $11,593 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 68 | 68 | $38,216 | $11,495 | 30.1% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 76 | 84 | $35,784 | $11,032 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 139 | $32,387 | $8,710 | 26.9% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 40 | 44 | $25,212 | $7,801 | 30.9% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2022 | 62 | 100 | $10,988 | $3,003 | 27.3% |
About Dr. Paul Derose, M.D
Dr. Paul Derose, M.D is a Radiation Oncology healthcare provider based in Richardson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659573780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Derose, M.D has received a total of $45,356 in payments from pharmaceutical and medical device companies, with $568.89 received in 2024. These payments were reported across 102 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($31,500).
As a Medicare-enrolled provider, Derose has provided services to 3,146 Medicare beneficiaries, totaling 10,500 services with total Medicare billing of $686,084. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Richardson, TX
- Active Since 06/01/2007
- Last Updated 10/28/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1659573780
Products in Payments
- Optune (Device) $26,200
- Oncology (Device) $14,878
- SIR-Spheres Microspheres (Device) $116.67
- IMFINZI (Biological) $114.30
- OSTEOCOOL RF ABLATION (Device) $94.40
- STRATTICE (Device) $86.43
- ALLODERM (Device) $73.21
- TrueBeam (Device) $48.27
- Doptelet (Drug) $39.39
- Kyprolis (Biological) $35.28
- JAKAFI (Drug) $33.68
- ZEPZELCA (Drug) $32.19
- LYNPARZA (Drug) $31.40
- ERLEADA (Drug) $28.44
- FASLODEX (Drug) $28.17
- LONSURF (Drug) $27.11
- OPDIVO (Biological) $25.09
- Varian Ethos Treatment Planning (Device) $23.57
- TEPMETKO (Drug) $22.67
- BLENREP (Biological) $22.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.